What changed from existing technology?
This study looked at how changes in blood sugar levels during stress affect the chance of dying in ICU patients with heart failure. It found that tracking these changes over time and looking at the total stress on blood sugar levels could help predict patient outcomes.
This study is the first to analyze the dynamic trajectories of the stress hyperglycemia ratio (SHR) and its cumulative burden (CumSHR) in ICU patients with heart failure, moving beyond single-time-point measurements to better understand their prognostic significance.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
hyperglycemia burden with in-hospital mortality in ICU patients with heart failure: a retrospective cohort study. Heart failure (HF) is a major global health
Title ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
The findings suggest that tracking the dynamic changes in the stress hyperglycemia ratio (SHR) and its cumulative burden (CumSHR) could improve risk stratification and clinical decision-making for ICU patients with heart failure.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.